The prognostic value of T1 bladder cancer substaging: A single institution retrospective study

Urologia Internationalis

Volumn 92, Issue 2, 2014, Pages 150-156

  Soukup, V ^a   Duskova J ^b   Pesl M ^a   Capoun O ^a   Feherova Z ^a   Zamecnik L ^a   Hanus T ^a   Babjuk, M ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Disease specific survival; Overall survival; Progression; Recurrence; T1 substaging; Urothelial carcinoma of the urinary bladder

Indexed keywords

AGED; ARTICLE; BCG VACCINATION; BLADDER TUMOR; CANCER PROGNOSIS; CANCER STAGING; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LAMINA PROPRIA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH MUSCLE; TRANSURETHRAL RESECTION; TUMOR INVASION; ADOLESCENT; ADULT; ANATOMIC LANDMARK; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SIZE; CANCER SPECIFIC SURVIVAL; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG INSTILLATION; LAMINA PROPRIA INVASION; MUSCLE INVASIVE BLADDER CANCER; PROGRESSION FREE SURVIVAL; T1 BLADDER CANCER; BLADDER; DISEASE COURSE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; TIME; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

BCG VACCINE; MITOMYCIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84900376094     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000355358     Document Type: Article

References (29)

1. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al: Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466-475. (Pubitemid 43259554)
2. Altieri VM, Castellucci R, Palumbo P, Verratti V, Sut M, Olivieri R, Manco R, Ricciardulli S, Nicolai M, Criniti P, Tenaglia RL: Recurrence and progression in non-muscleinvasive bladder cancer using EORTC risk tables. Urol Int 2012; 89: 61-66.
3. Reljic A, Trnski D: We abandoned 'superficial bladder cancer': we accepted 'non-muscle-invasive bladder cancer', but ...-on occasion of the 10th anniversary of the first EAU Guidelines on bladder cancer. Urol Int 2012; 88: 486-487.
4. Dixon JS, Gosling JA: Histology and fine structure of the muscularis mucosae of the human urinary bladder. J Anat 1983; 136: 265-271. (Pubitemid 13109121)
5. Younes M, Sussman J, True LD: The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer 1990; 66: 543-548. (Pubitemid 20233454)
6. Hasui Y, Osada Y, Kitada S, et al: Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer. Urology 1994; 43: 782-786. (Pubitemid 24174465)
7. Holmang S, Hedelin H, Anderstrom C, et al: The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol 1997; 157: 800-803.
8. Smits G, Schaafsma E, Kiemeney L, et al: Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. Urology 1998; 52: 1009-1013.
9. Hermann GG, Horn T, Steven K: The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer. J Urol 1998; 159: 91-94. (Pubitemid 27525578)
10. Babjuk M, Oosterlinck W, Sylvester R, et al: EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2011; 59: 997-1008.
11. Sobin DH, Wittekind C (eds): TNM Classification of Malignant Tumours, ed. 6. New York, Wiley-Liss, 2002, pp 199-202.
12. Mostofi FK, Sobin LH, Torloni H: Histopathological typing of urinary bladder tumors; in Mostofi FK, Sobin LH, Torloni H (eds): International Classification of Tumors. Geneva, WHO, 1973.
13. Kaplan E, Meier P: Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
14. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
15. Cox DR: Regression models and life-tables. J R Stat Soc 1972; 34: 187-220.
16. Angulo JC, Lopez JI, Grignon DJ, et al: Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer. Urology 1995; 45: 47-53.
17. Bernardini S, Billerey C, Martin M, et al: The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma. J Urol 2001; 165: 42-46.
18. Orsola A, Trias I, Raventós CX, et al: Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol 2005; 48: 231-238. (Pubitemid 40957095)
19. Andius P, Johansson SL, Holmang S: Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion. Urology 2007; 70: 758-762. (Pubitemid 350030224)
20. Mhawech-Fauceglia P, Fischer G, Alvarez V Jr, et al: Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder carcinoma using a panel of biomarkers: a high throughput tissue microarray analysis. BJU Int 2007; 100: 1182-1187. (Pubitemid 47537646)
21. Faivre d'Arcier B, Celhay O, Safsaf A, et al: T1 bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a/T1b). A multicenter study by the French Urological Association (CCAFU). Prog Urol 2010; 20: 440-449.
22. van Rhijn BW, van der Kwast TH, Alkhateeb SS, et al: A new and highly prognostic system to discern T1 bladder cancer substage. Eur Urol 2012; 61: 378-384.
23. Platz CE, Cohen MB, Jones MP, et al: Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol 1996; 9: 1035-1039. (Pubitemid 26393718)
24. Kondylis FI, Demirci S, Ladaga L, et al: Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma. J Urol 2000; 163: 1120-1123. (Pubitemid 30169375)
25. Shariat SF, Weizer AZ, Green A, et al: Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder. Urology 2000; 56: 735-740.
26. Gohji K, Nomi M, Okamoto M, et al: Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladder. Urology 1999; 53: 308-313. (Pubitemid 29063317)
27. Cheng L, Weaver AL, Neumann RM, et al: Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: a new proposal. Cancer 1999; 86: 1035-1043. (Pubitemid 29439859)
28. van Rhijn BW, Liu L, Vis AN, et al: Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer. BJU Int 2012; 110: 1169-1176.
29. Oosterlinck W, Lobel B, Jakse G, Malmström PU, Stöckle M, Sternberg C; European Association of Urology (EAU) Working Group on Oncological Urology: Guidelines on bladder cancer. Eur Urol 2002; 41: 105-112.